News for Atomo Diagnostics Limited (AT1.AX)

Published at

Mar 24, 2025 7:08 AM

by themarketherald.com.au

mixed

mixed

ASX Market Close: Index treads water on Budget Eve | Monday March 25, 2025

The ASX200 flat at 7,936 points. Discretionary was the best performing sector,…

ERW.AX AZEK AT1.AX SM1.AX MHK.AX

Read more →
Published at

Mar 3, 2025 2:00 PM

by gurufocus.com

positive

positive

Atomo Diagnostics Ltd (ASX:AT1) (H1 2025) Earnings Call Highlights: Revenue Growth and Strategic Market Expansion

Release Date: March 03, 2025For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Atomo Diagnosti

AT1.AX

Read more →
Published at

Mar 3, 2025 1:02 PM

by gurufocus.com

neutral

neutral

Half Year 2025 Atomo Diagnostics Ltd Earnings Call Transcript

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NAT1.AX - Atomo Diagnostics LtdHalf Year 2025 Atomo Diagnostics Ltd Earnings CallMar 03, 2025 /

AT1.AX

Read more →
Published at

Oct 25, 2024 3:04 PM

by smallcaps.com.au

mixed

mixed

Weekly wrap: WiseTech relief rally helps market to bounce higher

After days of fairly salacious headlines around WiseTech founder Richard White and his penchant for delivering mansions to girlfriends, the company pushed

YRL.AX RMD.AX MIN.AX AT1.AX WOW.AX VR1.AX COL.AX MTS.AX

Read more →
Published at

Oct 23, 2024 2:51 AM

by smallcaps.com.au

positive

positive

Atomo Diagnostics secures $2.44m grant to develop first rapid active syphilis self-test

Atomo Diagnostics (ASX: AT1) has again been recognised by the Australian government with the award of a $2.44 million grant to develop a unique syphilis

AT1.AX

Read more →
Published at

Sep 14, 2024 3:03 AM

by gurufocus.com

positive

positive

Atomo Diagnostics Ltd (ASX:AT1) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Improved Margins

Release Date: February 26, 2024For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Total revenu

AT1.AX

Read more →
Published at

Jun 19, 2024 4:35 AM

by themarketherald.com.au

mixed

mixed

Biotron jumps over 14% on latest HIV Phase 2 results; liquidity notably boosted

Shares in otherwise thinly traded healthcare microcap Biotron Limited (ASX:BIT) jumped 14.6% on Wednesday following trial results.

AT1.AX BITRF BIT.AX

Read more →
Published at

Jun 12, 2024 2:00 AM

by themarketherald.com.au

positive

positive

Atomo’s HIV self-test kits being rolled out by Canberra in $1.3M contract

Atomo Diagnositcs (ASX:AT1) has confirmed it will make roughly $1.3M over 2 years by taking part in a Federal HIV testing program.

AT1.AX

Read more →
Published at

May 16, 2024 5:32 AM

by smallcaps.com.au

positive

positive

Atomo Diagnostics boosted by federal funding for HIV prevention and self-test expansion

Medical device company Atomo Diagnostics (ASX: AT1) has welcomed the Australian government's commitment to fund the expansion of self-testing procedures

AT1.AX

Read more →
Published at

Apr 15, 2024 5:36 AM

by themarketherald.com.au

mixed

mixed

Market Update: Star’s tumble as NSW Inquiry ramps up

The ASX200 has been trading down around half a per cent, but the Star Entertainment Group (ASX:SGR) is down 5.45% as current and former executives begin to appear before a NSW Inquiry into its Sydney casino operations.

PLL.AX CYG.AX BGD.AX AT1.AX SGR.AX IMU.AX

Read more →
Published at

Apr 15, 2024 3:14 AM

by themarketherald.com.au

positive

positive

Atomo Diagnostics orders HIV self-test kits for third world countries

Atomo Diagnostics (ASX:AT1), has put in a purchase order from Viatris Healthcare for HIV self-tests, valued at approximately $570,000.

AT1.AX

Read more →
Published at

Mar 29, 2024 12:50 AM

by gurufocus.com

positive

positive

Q1 2024 Atomo Diagnostics Ltd Activities Report Call Transcript

Oct 26, 2023 / 12:00AM GMTJohn Kelly - Atomo Diagnostics Limited - Founder, MD & CEO Good morning, everyone. My name is John Kelly, I'm the Managing Director fo

AT1.AX

Read more →
Published at

Mar 29, 2024 12:50 AM

by gurufocus.com

positive

positive

Full Year 2023 Atomo Diagnostics Ltd Earnings Call Transcript

Aug 24, 2023 / 12:00AM GMTWilliam Edward Souter - Atomo Diagnostics Limited - CFO I think we're quite ready to get it, John?John Michael Kelly - Atomo Diagnosti

AT1.AX

Read more →
Published at

Apr 30, 2023 7:20 PM

by stockhead.com.au

mixed

mixed

Check Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m+ quarterly sales

The healthcare sector is ripe for disruption and artificial intelligence will play a big part in future drug discovery.

PSQ.AX PGC.AX OSX.AX OPT.AX OPT NOXOF NOX.AX IUGNF IMU.AX GSS.AX CYP.AX CKDXF BPH.AX ATX.AX 4DX.AX ZNO.AX SCU.AX RSH.AX PXSLY PXS.AX PAB.AX OCC.AX NC6.AX KZA.AX KMLXF IHL.AX IDT.AX FDMDF DVL.AX CMP.AX BITRF BIT.AX ARUXF AMT.AX ACR.AX 1AD.AX ZLD.AX VTG.AX VLS.AX UBI.AX TD1.AX SOMNF SOM.AX RNO.AX RHY.AX RHT.AX RGS.AX RAC.AX PYC.AX PNV.AX PCK.AX PBP.AX OVN.AX OSL.AX ONE.AX OIL.AX NYR.AX NXSCF NXS.AX MXC.AX MX1.AX MVF.AX MEM.AX MEB.AX MDR.AX MDC.AX MDBIF LBT.AX IVX.AX IPDQF IPD.AX IMRNW IMRN IMM.AX IMC.AX ICR.AX HCT.AX GTG.AX GLH.AX EYE.AX DXB.AX CSL.AX CPH.AX CGS.AX CAN.AX CALZF CAJ.AX BXN.AX BWXXF BWX.AX BNOEF BNO.AX AT1.AX ARX.AX AMDHF ALC.AX ADR.AX ADO.AX 1ST.AX

Read more →
Published at

Apr 5, 2023 5:06 AM

by stockhead.com.au

positive

positive

ASX Health Stocks: Atomo and Volpara strike $1m+ contracts; Estia tells Bain to improve $3 offer

Atomo Diagnostics (ASX:AT1) announced a ‘take-or-pay’ agreement with long term partner Viatris for its HIV Self-Test in South Africa.

IMU.AX EHE.AX AT1.AX

Read more →
Published at

Mar 22, 2023 3:41 AM

by stockhead.com.au

mixed

mixed

ASX Small Caps Lunch Wrap: Are you ready for the Great Monkey Uprising?

The ASX has risen 0.9% this morning, but it really doesn't matter because we're all about to be murdered by rampaging monkeys. Possibly.

RCL.AX QFEEF QFE.AX MRQ.AX MKR.AX HNR.AX FIN.AX CL8.AX ARV.AX TSLA PCL.AX NET.AX FIJ.AX BPH.AX ATS.AX SIX.AX MXC.AX MEB.AX MDBIF MCT.AX IVX.AX GTG.AX GRVI GENE FAU.AX BPP.AX AUK.AX AT1.AX ADS.AX

Read more →
Published at

Feb 1, 2023 5:46 PM

by stockhead.com.au

mixed

mixed

Check Up: The FDA refuses to give CBD a green light, but market doesn’t seem to care

The FDA declined regulate CBD-based supplements and food citing safety reasons, but the CBD index keeps going up.

PYC.AX PSQ.AX PGC.AX MSB.AX KZA.AX EYE.AX DVL.AX CAN.AX BXN.AX BNOEF BNO.AX ADO.AX SOMNF SOM.AX RSH.AX RHT.AX RGS.AX OSX.AX OSL.AX ONE.AX OIL.AX NXSCF NXS.AX MEB.AX MDC.AX MDBIF KMLXF IVX.AX IUGNF IMU.AX IDT.AX GLH.AX CYP.AX CMP.AX CAJ.AX AT1.AX ADR.AX 1ST.AX ZNO.AX ZLD.AX VTG.AX VLS.AX UBI.AX TD1.AX SCU.AX RNO.AX RHY.AX RAC.AX PXSLY PXS.AX PNV.AX PCK.AX PBP.AX PAB.AX OVN.AX OPT.AX OPT OCC.AX NYR.AX NOXOF NOX.AX NC6.AX MXC.AX MX1.AX MVF.AX MEM.AX MDR.AX LBT.AX IPDQF IPD.AX IMRNW IMRN IMM.AX IMC.AX IHL.AX ICR.AX HCT.AX GTG.AX GSS.AX FDMDF DXB.AX CPH.AX CKDXF CGS.AX CALZF BWXXF BWX.AX BPH.AX BITRF BIT.AX ATX.AX ARX.AX ARUXF AMT.AX AMDHF ALC.AX ACR.AX 4DX.AX 1AD.AX

Read more →
Published at

Jan 19, 2023 5:50 PM

by stockhead.com.au

mixed

mixed

Check Up: Japan’s startup OUI wants to halve the world’s blindness with its smartphone device

Japanese startup OUI Inc says it is on a mission to halve the world's blindness with its smartphone-based device.

ZNO.AX ZLD.AX RAP.AX PSQ.AX PIQ.AX PBP.AX PAA.AX MXC.AX IPDQF IPD.AX IDT.AX GLH.AX CGS.AX BXN.AX 1AD.AX SOMNF SOM.AX SHL.AX RSH.AX RGS.AX PGC.AX PCK.AX OVN.AX OSX.AX OSL.AX OIL.AX NYR.AX NXSCF NXS.AX MX1.AX MDC.AX LBT.AX KZIA KZA.AX KMLXF IVX.AX IMMP IMM.AX IHL.AX GSS.AX FDMDF DVL.AX CYP.AX CPH.AX CAN.AX BWXXF BWX.AX BPH.AX BNOEF BNO.AX BITRF BIT.AX AT1.AX ARX.AX AKU.TO AKU ADR.AX 4DX.AX 1ST.AX VTG.AX VLS.AX UBI.AX SCU.AX RNO.AX RHY.AX RHT.AX RAC.AX PYC.AX PXSLY PXS.AX PNV.AX PAB.AX OPT.AX OPT ONE.AX OCC.AX NOXOF NOX.AX NC6.AX MVF.AX MEM.AX MEB.AX MDR.AX MDBIF IUGNF IMU.AX IMRNW IMRN IMC.AX ICR.AX HCT.AX EYE.AX DXB.AX CMP.AX CKDXF CALZF CAJ.AX ATX.AX ARUXF AMT.AX AMDHF ALC.AX ADO.AX ACR.AX

Read more →
Published at

Jan 4, 2023 6:02 PM

by stockhead.com.au

mixed

mixed

Check Up: Moderna posts crazy cancer vaccine results, says melanoma recurrence down by almost half

Moderna’s stock price rose in late December after the company revealed that a vaccine for melanoma showed encouraging results.

TD1.AX RSH.AX PCK.AX MX1.AX KMLXF DVL.AX CAJ.AX BNOEF BNO.AX ARX.AX ADR.AX 1ST.AX ZNO.AX RHY.AX RAC.AX PYC.AX PSQ.AX PGC.AX OVN.AX OSX.AX ONE.AX OCC.AX NOXOF NOX.AX NC6.AX MDC.AX KZA.AX IPDQF IPD.AX IDT.AX GTG.AX CYP.AX CPH.AX CAN.AX BXN.AX BWXXF BWX.AX BPH.AX BITRF BIT.AX ATX.AX ZLD.AX VTG.AX VLS.AX UBI.AX SOMNF SOM.AX SCU.AX RNO.AX RHT.AX RGS.AX PXSLY PXS.AX PNV.AX PBP.AX PAB.AX OSL.AX OPT.AX OPT OIL.AX NYR.AX NXSCF NXS.AX MXC.AX MVF.AX MEM.AX MDR.AX LBT.AX IVX.AX IUGNF IMU.AX IMRNW IMRN IMM.AX IMC.AX IHL.AX ICR.AX HCT.AX GSS.AX GLH.AX FDMDF EYE.AX DXB.AX CMP.AX CKDXF CGS.AX CALZF AT1.AX ARUXF AMT.AX AMDHF ALC.AX ADO.AX ACR.AX 4DX.AX 1AD.AX

Read more →
Published at

Dec 22, 2022 3:01 PM

by stockhead.com.au

mixed

mixed

After a dismal year for ASX health stocks 2023 is showing signs of a recovery

The ASX health sector is down more than 8% as 2022 comes to end but in signs of optimism for 2023, Morgans has a basket of stocks to watch.

TD1.AX PME.AX NURPF NEU.AX NAN.AX MEM.AX KZIA KZA.AX HXL.AX HHI.AX EX1.AX SCU.AX PIQ.AX OSL.AX MVF.AX EBO.NZ EBO.AX CSLN.MX CSLLY CSL.AX CMXHF BXPHF BOT.AX AVR.AX AMEUF AJJ.AX ADO.AX ZLDAF ZLD.AX WFL.AX VIP.AX VHT.AX UBI.AX SIG.AX REG.AX PNV.AX PBP.AX OVN.AX NTI.AX MEB.AX MDBIF LCT.AX CSX.AX CRON CPH.AX COPHF CAU.AX CALZF AT1.AX ARX.AX ANR.AX

Read more →